SCHEMBL5496470

SCHEMBL5496470

CCOc1cc(C(CC)N2Cc3cccc(NC(=O)C4CC4)c3C2=O)ccc1OC(F)F

nearest known ligand 0.43

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
NR1I2 O75469 1/20 0.42
UGCG Q16739 1/20 0.42
PDE4B Q07343 11/20 0.42
PDE4C Q08493 11/20 0.42
PDE4A P27815 6/20 0.42
PDE4D Q08499 6/20 0.42
TP53 P04637 1/20 0.41
HTR2B P41595 1/20 0.41
RECQL P46063 1/20 0.40
MAPT P10636 1/20 0.38
POLB P06746 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1143639 0.94 PDE4A (0.42) NR1I2UGCGPDE4BPDE4CPDE4A
SCHEMBL1143520 0.93 PDE4B (0.49) NR1I2UGCGPDE4BPDE4CPDE4A
SCHEMBL1143947 0.93 PDE4A (0.46) NR1I2UGCGPDE4BPDE4CPDE4A
SCHEMBL1143603 0.92 TP53 (0.41) NR1I2UGCGPDE4BPDE4CPDE4A
SCHEMBL1143737 0.92 TP53 (0.44) NR1I2UGCGPDE4BPDE4CPDE4A
SCHEMBL1143726 0.92 PDE4B (0.49) PDE4BPDE4CPDE4APDE4DHTR2B
SCHEMBL13002994 0.91 PDE4B (0.51) NR1I2UGCGPDE4BPDE4CPDE4A
SCHEMBL5511996 0.91 PDE4B (0.51) NR1I2UGCGPDE4BPDE4CPDE4A
SCHEMBL1143748 0.87 MAPT (0.37) NR1I2UGCGPDE4BPDE4CPDE4A
SCHEMBL1144302 0.87 PDE4A (0.41) PDE4BPDE4CPDE4APDE4DTP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1496878-A4 METHODS FOR IDENTIFICATION OF MODULATORS OF ANGIOGENESIS, COMPOUNDS DISCOVERED THEREBY, AND METHODS OF TREATMENT USING THE COMPOUNDS CELGENE CORP (US) 2007-12-26 EP disclosed
EP-1496878-A1 METHODS FOR IDENTIFICATION OF MODULATORS OF ANGIOGENESIS, COMPOUNDS DISCOVERED THEREBY, AND METHODS OF TREATMENT USING THE COMPOUNDS CELGENE CORPORATION (US) 2005-01-19 EP disclosed
WO-2003086373-A1 METHODS FOR IDENTIFICATION OF MODULATORS OF ANGIOGENESIS, COMPOUNDS DISCOVERED THEREBY, AND METHODS OF TREATMENT USING THE COMPOUNDS CELGENE CORPORATION (US) 2003-10-23 WO disclosed